Floatz logo

Tirzepatide

Alcohol Dependence

Anders Fink-Jensen, MD, DMSciprotein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Alcohol Dependence cohort.

Asset / SponsorPhaseRating
Naltrexone
Inventage Lab., Inc.
Phase 4BBB
Acamprosate
Hanyang University Seoul Hospital
Phase 4BBB
Seroquel®
University of Texas Southwestern Medical Center
Phase 4BBB
Cipralex
University of Texas Southwestern Medical Center
Phase 4BBB
Topamax
Stanford University
Phase 4BB

View all 26 →

Same molecule, other indications

Tirzepatide is also rated in:

type 1 diabetes mellitusDormant
BBB
Indicative ·
78 / 100
View asset →
psoriatic arthritisDormant
BBB
Indicative ·
74 / 100
View asset →
diastolic heart failureDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →